Atlas Trials

Safety and Clinical and Virologic Outcomes in CKD Patients Treated With Nirmatrelvir-ritonavir

Clinical trial NCT05624840 · COMPLETED

Trial details

NCT number
NCT05624840
Sponsor
Chinese University of Hong Kong
Status
COMPLETED
Study type
OBSERVATIONAL
COVID-19Chronic Kidney Disease stage4Chronc Kidney Disease Stage 5
Start date
2022-11-07
Primary completion
2023-01-31
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.